scholarly journals Anti-inflammatory Drugs for Cancer Prevention and Treatment: Emerging Options

2012 ◽  
Vol 04 (12) ◽  
Author(s):  
Reddanna Pallu
Keyword(s):  
Cancer Prevention ◽  
Prevention And Treatment ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention

2016 ◽  
Vol 43 (1) ◽  
pp. 65-77 ◽  
Author(s):  
Asad Umar ◽  
Vernon E. Steele ◽  
David G. Menter ◽  
Ernest T. Hawk
Keyword(s):  
Cancer Prevention ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

scholarly journals Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

1999 ◽  
Vol 81 (1) ◽  
pp. 62-68 ◽  
Author(s):  
J-P Collet ◽  
C Sharpe ◽  
E Belzile ◽  
J-F Boivin ◽  
J Hanley ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Prevention ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
Colorectal Cancer Prevention

scholarly journals Melatonin May Increase Anticancer Potential of Pleiotropic Drugs

2018 ◽  
Vol 19 (12) ◽  
pp. 3910 ◽  
Author(s):  
Bianka Bojková ◽  
Peter Kubatka ◽  
Tawar Qaradakhi ◽  
Anthony Zulli ◽  
Karol Kajo
Keyword(s):  
Cancer Risk ◽  
Adjuvant Therapy ◽  
Cancer Prevention ◽  
Metabolic Disorders ◽  
Preclinical Studies ◽  
Beneficial Effects ◽  
Prevention Therapy ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
Cancer And Inflammation

Melatonin (N-acetyl-5-methoxytryptamine) is not only a pineal hormone, but also an ubiquitary molecule present in plants and part of our diet. Numerous preclinical and some clinical reports pointed to its multiple beneficial effects including oncostatic properties, and as such, it has become one of the most aspiring goals in cancer prevention/therapy. A link between cancer and inflammation and/or metabolic disorders has been well established and the therapy of these conditions with so-called pleiotropic drugs, which include non-steroidal anti-inflammatory drugs, statins and peroral antidiabetics, modulates a cancer risk too. Adjuvant therapy with melatonin may improve the oncostatic potential of these drugs. Results from preclinical studies are limited though support this hypothesis, which, however, remains to be verified by further research.

Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention

2000 ◽  
Vol 51 (1) ◽  
pp. 511-523 ◽  
Author(s):  
John A. Baron ◽  
Robert S. Sandler
Keyword(s):  
Cancer Prevention ◽  
Inflammatory Drugs ◽  
Anti Inflammatory
Sign in / Sign up

Export Citation Format

Share Document